EB-101 Healed Wounds, Eased Pain Up to Six Years in Trial

EB-101 Healed Wounds, Eased Pain Up to Six Years in Trial

298916

EB-101 Healed Wounds, Eased Pain Up to Six Years in Trial

Treatment with Abeona Therapeutics‘ investigational cell therapy EB-101 led to successful wound healing and eased pain in seven adults with recessive dystrophic epidermolysis bullosa (RDEB) who were followed for up to six years in a clinical trial. “The updated Phase 1/2a results showed safety and durable efficacy follow up, with EB-101 treated wounds continuing to show a considerable reduction in both wound burden and associated long-term pain for up to six years,” Vishwas Seshadri, PhD,…

You must be logged in to read/download the full post.